Stringer KA - Search Results

1

Tissue plasminogen activator (tPA) inhibits human neutrophil superoxide anion production in vitro.

Stringer KA, Lindenfeld J, Repine AJ, Cohen Z, Repine JE. Stringer KA, et al. Inflammation. 1997 Feb;21(1):27-34. doi: 10.1023/a:1027334607606. Inflammation. 1997. PMID: 9179619

2

Hirudins: antithrombin anticoagulants.

Stringer KA, Lindenfeld J. Stringer KA, et al. Ann Pharmacother. 1992 Dec;26(12):1535-40. doi: 10.1177/106002809202601211. Ann Pharmacother. 1992. PMID: 1482812 Review.

3

The effect of three different oral doses of verapamil on the disposition of theophylline.

Stringer KA, Mallet J, Clarke M, Lindenfeld JA. Stringer KA, et al. Eur J Clin Pharmacol. 1992;43(1):35-8. doi: 10.1007/BF02280751. Eur J Clin Pharmacol. 1992. PMID: 1505606 Clinical Trial.

4

The GUSTO trial: is the open-artery hypothesis proven?

Stringer KA, Lindenfeld J. Stringer KA, et al. Ann Pharmacother. 1994 Jan;28(1):97-8. doi: 10.1177/106002809402800118. Ann Pharmacother. 1994. PMID: 8123971 No abstract available.

5

Antiinflammatory activity of tissue plasminogen activator in the carrageenan rat footpad model.

Stringer KA, Bose SK, McCord JM. Stringer KA, et al. Free Radic Biol Med. 1997;22(6):985-8. doi: 10.1016/s0891-5849(96)00484-4. Free Radic Biol Med. 1997. PMID: 9034237

6

Validity of the GUSTO trial's main conclusion--author's reply. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.

Stringer KA. Stringer KA. Pharmacotherapy. 1997 Sep-Oct;17(5):1043. Pharmacotherapy. 1997. PMID: 9324198 No abstract available.

7

Tissue plasminogen activator (tPA) inhibits interleukin-1 induced acute lung leak.

Stringer KA, Hybertson BM, Cho OJ, Cohen Z, Repine JE. Stringer KA, et al. Free Radic Biol Med. 1998 Jul 15;25(2):184-8. doi: 10.1016/s0891-5849(98)00047-1. Free Radic Biol Med. 1998. PMID: 9667494

8

Tissue plasminogen activator inhibits reactive oxygen species production by macrophages.

Stringer KA. Stringer KA. Pharmacotherapy. 2000 Apr;20(4):375-9. doi: 10.1592/phco.20.5.375.35059. Pharmacotherapy. 2000. PMID: 10772365

9

An institution-specific heparin titration nomogram: development, validation, and assessment of compliance.

Sherman DS, Clarke SH, Lefkowitz JB, Valuck RJ, Lindenfeld J, Stringer KA. Sherman DS, et al. Among authors: stringer ka. Pharmacotherapy. 2001 Oct;21(10):1167-74. doi: 10.1592/phco.21.15.1167.33895. Pharmacotherapy. 2001. PMID: 11601661 Clinical Trial.

10

Administration of exogenous tissue plasminogen activator reduces oedema in mice lacking the tissue plasminogen activator gene.

Stringer KA, Dunn JS, Gustafson DL. Stringer KA, et al. Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):327-30. doi: 10.1111/j.1440-1681.2004.03999.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15191406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters